Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

E-ISSN： 1873-4286|18|12|1580-1592

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.12, 2012-04, pp. : 1580-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 771-785

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 540-550

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists

By Vasiliadis H.-M. Elie R. Dewar K.M.

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite